Doris Benbrook to Survival Analysis
This is a "connection" page, showing publications Doris Benbrook has written about Survival Analysis.
Connection Strength
0.096
-
A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Nov; 127(2):356-61.
Score: 0.096